The molecular legacy of apoptosis in transplantation

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1378-1384

  Pallet, N ^a   Dieude M ^a   Cailhier, J ^a   Hebert M ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alloimmunity; apoptosis; cell death; membrane vesicles; transplantation

Indexed keywords

ALLOGRAFT; APOPTOSIS; CELL DEATH; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LEUKOCYTE; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; TRANSPLANTATION;

APOPTOSIS; HUMANS; PROTEOLYSIS; TRANSPLANTATION;

EID: 84861792507     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04015.x     Document Type: Review

References (39)

1. Berda-Haddad Y, Robert S, Salers P, et al,. Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1alpha. Proc Natl Acad Sci U S A 2011; 108: 20684-20689.
2. Thery C, Boussac M, Veron P, et al,. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001; 166: 7309-7318.
3. Galluzzi L, Vitale I, Abrams JM, et al,. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120.
4. Keller M, Ruegg A, Werner S, Beer HD,. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008; 132: 818-831.
5. He S, Wang L, Miao L, et al,. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100-1111.
6. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G,. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-714.
7. Galluzzi L, Vanden Berghe T, Vanlangenakker N, et al,. Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol; 289: 1-35.
8. Poon IK, Hulett MD, Parish CR,. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ 2010; 17: 381-397.
9. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV,. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008; 118: 1657-1668.
10. Lauber K, Bohn E, Krober SM, et al,. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003; 113: 717-730.
11. Truman LA, Ford CA, Pasikowska M, et al,. CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 2008; 112: 5026-5036.
12. Jinushi M, Nakazaki Y, Dougan M, Carrasco DR, Mihm M, Dranoff G,. MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF. J Clin Invest 2007; 117: 1902-1913.
13. Choy JC, Cruz RP, Kerjner A, et al,. Granzyme B induces endothelial cell apoptosis and contributes to the development of transplant vascular disease. Am J Transplant 2005; 5: 494-499.
14. Liptak P, Kemeny E, Morvay Z, et al,. Peritubular capillary damage in acute humoral rejection: An ultrastructural study on human renal allografts. Am J Transplant 2005; 5: 2870-2876.
15. Ishii Y, Sawada T, Kubota K, Fuchinoue S, Teraoka S, Shimizu A,. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int 2005; 67: 321-332.
16. Saiura A, Sata M, Hiasa K, et al,. Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy. Arterioscler Thromb Vasc Biol 2004; 24: 1886-1890.
17. Schwartz BR, Karsan A, Bombeli T, Harlan JM,. A novel beta 1 integrin-dependent mechanism of leukocyte adherence to apoptotic cells. J Immunol 1999; 162: 4842-4848.
18. Shimizu A, Yamada K, Sachs DH, Colvin RB,. Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Kidney Int 2002; 61: 1867-1879.
19. Laplante P, Sirois I, Raymond MA, et al,. Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis. Cell Death Differ 2010; 17: 291-303.
20. Cheng O, Thuillier R, Sampson E, et al,. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006; 6: 2292-2306.
21. Soulez M, Sirois I, Brassard N, et al,. Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells. Stem Cells 2010; 28: 810-820.
22. Cailhier JF, Sirois I, Laplante P, et al,. Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J Biol Chem 2008; 283: 27220-27229.
23. Soulez M, Pilon EA, Dieude M, et al,. The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. Circ Res 2012; 110: 94-104.
24. Park WD, Griffin MD, Cornell LD, Cosio FG, Stegall MD,. Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 2010; 21: 1987-1997.
25. Golpon HA, Fadok VA, Taraseviciene-Stewart L, et al,. Life after corpse engulfment: Phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J 2004; 18: 1716-1718.
26. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM,. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
27. Nagano H, Nadeau KC, Kusaka M, Heeman UW, Tilney NL,. Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats. Transplantation 1997; 64: 1602-1605.
28. Dehmel S, Wang S, Schmidt C, et al,. Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome. Eur J Immunol 2010; 40: 267-278.
29. Famulski KS, Einecke G, Sis B, et al,. Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010; 10: 810-820.
30. Thery C, Ostrowski M, Segura E,. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593.
31. Morelli AE,. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: Its impact on transplantation. Am J Transplant 2006; 6: 254-261.
32. Wang Z, Larregina AT, Shufesky WJ, et al,. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 2006; 6: 1297-1311.
33. Morelli AE, Larregina AT,. Apoptotic cell-based therapies against transplant rejection: Role of recipient's dendritic cells. Apoptosis 2010; 15: 1083-1097.
34. Sirois I, Raymond MA, Brassard N, et al,. Caspase-3-dependent export of TCTP: A novel pathway for antiapoptotic intercellular communication. Cell Death Differ 2011; 18: 549-562.
35. Peche H, Renaudin K, Beriou G, Merieau E, Amigorena S, Cuturi MC,. Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am J Transplant 2006; 6: 1541-1550.
36. Montecalvo A, Shufesky WJ, Stolz DB, et al,. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J Immunol 2008; 180: 3081-3090.
37. Walker JD, Maier CL, Pober JS,. Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes. J Immunol 2009; 182: 1548-1559.
38. Sis B, Einecke G, Chang J, et al,. Cluster analysis of lesions in nonselected kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant 2010; 10: 421-430.
39. O'Riordan E OT, Mendelev N, Patschan D, et al,. Urinary proteomic analysis of chronic allograft nephropathy. Proteomics Clin Appl 2008; 2: 1025-1035.